Article Information
History
- August 5, 2020.
Article Versions
- Version 1 (April 17, 2020 - 17:54).
- Version 2 (April 18, 2020 - 11:54).
- Version 3 (May 12, 2020 - 07:57).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ioanna Smyrlaki1,*,
- Martin Ekman2,*,
- Antonio Lentini1,
- Nuno Rufino de Sousa3,
- Natali Papanicolaou1,
- Martin Vondracek2,
- Johan Aarum2,
- Hamzah Safari2,
- Shaman Muradrasoli4,
- Antonio Gigliotti Rothfuchs3,
- Jan Albert2,3,
- Björn Högberg1 and
- Björn Reinius1,#
- 1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- 2Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
- 3Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
- 4Public Health Agency of Sweden, Solna, Sweden
- ↵#Correspondence to bjorn.reinius{at}ki.se
↵* Equal contribution
Posted August 05, 2020.
Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR
